Anticoagulation clinic marketing: bleeding warning signs, home INR testing, pharmacist collaborative practice and reminders

An anticoagulation clinic looks after people who take blood thinners, and its marketing reaches a reader at a careful moment. The person reading the page may have just started a blood thinner after a clot in the leg or lung, may take one for an irregular heart rhythm or a replaced heart valve, may be tired of driving to a lab for blood tests, or may be a family member who manages the pill box. The clinic may be run by pharmacists inside a hospital or a health system, by a cardiology or primary care practice, by an independent pharmacy, or by a team that follows patients who test at home. This guide covers what the federal patient pages say, the bleeding and clot warning signs that belong on every page, how to describe a pharmacist-run service whose scope is set state by state, how to write about home INR testing in the FDA words, what to say about doses, diet and results, prices, referral partners, reminder messages, privacy and patient stories.

Seven related topics have their own guides and are not repeated here. Pharmacy-based testing, the CLIA certificate of waiver and prescribing after a test are covered in our guide to pharmacist test-and-treat marketing, and pharmacy marketing in general in our guide to independent pharmacy marketing. Heart practice marketing, including the self-referral law and heart screening offers, is covered in our guide to cardiology practice marketing, and stroke programs in our guide to stroke center marketing. Clinics that bill for monitoring between visits should read our guides to remote patient monitoring marketing and chronic care management marketing. Portal messages are covered in our guide to patient portal messages.

What MedlinePlus, NHLBI, FDA and CDC say

MedlinePlus from the National Library of Medicine publishes the federal patient pages on blood thinners and the PT/INR blood test, the National Heart, Lung, and Blood Institute (NHLBI) covers treatment and recovery after a blood clot, FDA has a consumer page on home prothrombin time tests, and CDC published a guide to collaborative practice agreements between pharmacists and prescribers. The NHLBI pages were last updated in September 2022, the FDA page is current as of September 2018 and the CDC guide dates from 2017, so a clinic should quote each as a dated page and check it again before a campaign. The points that shape a clinic’s marketing:

• The MedlinePlus page Blood Thinners (last updated June 27, 2024) says blood thinners are medicines that prevent blood clots from forming, that they do not break up clots a person already has but can stop those clots from getting bigger, and that blood thinners may interact with certain foods, medicines, vitamins and alcohol. It says a person may need regular blood tests to check how well their blood is clotting, and that the goal is enough medicine to prevent clots but not so much that it causes bleeding. It names bleeding as the side effect seen more than any other and lists the signs of serious bleeding that mean a person should call their provider.
• The MedlinePlus page Prothrombin Time Test and INR (PT/INR) (last updated May 15, 2024) says the test checks whether a medicine that prevents blood clots is working the way it should, that the provider may change the dose based on the results, and that the provider says when the test is needed. It says a fingertip test may be done in a provider’s office or at home, that a person who has taken the medicine for a long time may be trained to use an at-home kit, and that a person using a home kit needs to review results with their provider. It says an INR that is too low may mean a risk of dangerous clots and one that is too high may mean a risk of dangerous bleeding, and that medicines, supplements, alcohol and foods high in vitamin K can affect results.
• The NHLBI pages Venous Thromboembolism: Treatment and Recovery (each last updated on September 20, 2022) say the provider works with the patient to decide which blood thinner is best based on their medical history, that a person may need blood thinners for several months or for a lifetime depending on the type of medicine and the cause of the clot, and that bleeding is a possible side effect, especially with other medicines that also thin the blood. The recovery page says bleeding from blood thinners can be life-threatening, to schedule a checkup or go to the emergency room for signs of excessive bleeding, and that INR blood tests are generally done at a provider’s office or a clinic, adding that FDA has approved several devices for self-testing.
• The FDA consumer page Prothrombin Time (content current as of September 27, 2018) says the doctor will prescribe a home test if a person needs one, that the person should follow the doctor’s instructions on the testing schedule, that the doctor may ask the person to use results to adjust their medicine, and that a person should never change the drugs they take without the doctor’s permission. It says to take the meter to the doctor’s office, have the doctor watch the person test, and compare the meter result with a sample the office tests.
• The CDC guide Advancing Team-Based Care Through Collaborative Practice Agreements (2017) says a collaborative practice agreement creates a formal practice relationship between a pharmacist and a prescriber and specifies which functions the prescriber delegates, that the functions vary from state to state based on the pharmacist’s scope of practice and the state’s collaborative practice laws, and that state laws for these agreements vary widely. Its state-by-state appendix is dated December 31, 2015, so a clinic checks the current law with its board of pharmacy and counsel.

Two points shape the marketing. First, a blood thinner can cause serious bleeding and a clot can travel to the lungs, so every page, message and tool must say when to seek care right away or call 911 before it offers an appointment. Second, the dose, the testing schedule and who may change a medicine are set by the prescriber and by state law, not by the marketing team. A clinic can explain its service well; it cannot promise that a patient will stay in range or that the medicine carries no risk.

Bleeding and clot warning signs on every page and in every tool

Put the agency warning signs on the clinic pages, above the booking button and the contact form. A short version a clinic can use, close to the MedlinePlus and NHLBI words: if you take a blood thinner, call your provider for any sign of serious bleeding, such as red or brown urine, red or black bowel movements, bleeding from the gums or nose that does not stop quickly, vomit that is brown or bright red, coughing up something red, menstrual bleeding much heavier than normal, a cut that does not stop bleeding, unusual bruising, severe pain such as a headache or stomachache, dizziness or weakness, or a serious fall or bump on the head. Go to the emergency room for signs of excessive bleeding. If you have chest pain, trouble breathing, cough up blood or faint, or you think you are having a medical emergency, call 911. Link the MedlinePlus and NHLBI pages so readers can check them, and have the clinic’s prescribers approve the final wording.

The same wording belongs on voicemail, after-hours messages, patient portal autoreplies, text replies, chat widgets and AI front desk tools. A message that says “I fell and hit my head” or “my nose will not stop bleeding” is not a scheduling request. The tool should give the emergency wording and the 911 line at once and alert staff, not judge the symptom, suggest a dose change or offer the next open INR slot. Our guides to AI chatbots on practice websites and answering services and AI receptionists cover how those tools hand off urgent messages.

Phrases that need rewriting:

• “Questions about bleeding? Book an INR check.” Put the warning signs and the 911 line first and the booking link after them.
• “Skip a dose if you notice bruising.” A dose change is the prescriber’s decision, and the FDA page says never change the drugs you take without the doctor’s permission. Remove it and give the warning signs instead.
• “Text us your INR anytime.” Say who reads messages, during which hours, how fast the clinic replies, that the inbox is not watched around the clock, and give the emergency wording and 911.

Who runs the clinic: pharmacists, prescribers and state law

Where pharmacists run an anticoagulation clinic, what they may do there depends on the state. The CDC guide says a collaborative practice agreement lets a prescriber delegate specific functions to a pharmacist, that the functions vary from state to state based on the pharmacist’s scope of practice and the state’s laws, and that functions under an agreement may include starting, changing or stopping medicine and ordering and interpreting lab tests where state law allows. It also says the terms used to describe this authority vary among states.

For marketing, that means the page describes the service the clinic actually provides under its agreement and its state’s rules, and names who is responsible. A clinic page can say that [Clinician name, license] runs the clinic under a written agreement with [Clinician name, license], what the pharmacist does at each visit, and who the patient calls about a dose. It should not claim powers the agreement does not grant, or describe the pharmacist with a title the state does not allow. A clinic that serves patients in more than one state checks each state’s law, because an agreement that works in one may not work in another. Running the INR test in the clinic also brings in the federal lab rules, which our test-and-treat guide covers.

Phrases that need rewriting:

• “Our pharmacists manage your blood thinner, no doctor needed.” Under the CDC guide, the pharmacist acts under an agreement with a prescriber. Name the prescriber and describe the agreement.
• “We prescribe your blood thinner.” Say what the clinic does only after checking the agreement and the state’s law with counsel.
• “Same service in every state.” The CDC guide says the functions vary from state to state. Describe the service for each state the clinic serves.

Home INR testing in the FDA words

Home testing is the feature that sells an anticoagulation service to a patient who is tired of lab visits, and it is where pages promise more than the agency pages support. The FDA consumer page says the doctor will prescribe a home test if a person needs it, that the person follows the doctor’s instructions on the testing schedule, and that the doctor may ask the person to use results to adjust the amount of medicine. It says the person should take the meter to the doctor’s office, have the doctor watch them test, and compare the meter result with a sample the office tests. MedlinePlus says a person who has taken the medicine for a long time may be trained to use an at-home kit and needs to review results with their provider, who says how they want to receive results.

A home testing page can describe the service in those words: who decides whether home testing suits a patient, how the clinic trains patients and checks their meters against an office test, how patients send results, who reviews them, and how fast the clinic calls back. Name no meter, strip or maker. NHLBI says FDA has approved several devices for self-testing; a clinic that wants to state the FDA status of the meter it supplies checks it in an FDA database and has counsel review the wording.

Phrases that need rewriting:

• “Test at home and adjust your own dose.” The FDA page says the doctor may ask a person to use results to adjust medicine, and never to change drugs without the doctor’s permission. Say who sets the dose.
• “Home testing for everyone on a blood thinner.” MedlinePlus describes home kits for people who have taken the medicine for a long time and are trained. Say the prescriber decides who qualifies.
• “Lab-accurate results at home.” A comparative accuracy claim. Describe the meter check the FDA page sets out instead.
• “No more blood draws, ever.” The FDA page says to compare the meter with an office test. Say when office tests still happen.

Doses, diet and “stay in range” promises

A clinic page that explains why INR tests matter can quote MedlinePlus: an INR that is too low may mean a risk of dangerous clots, one that is too high may mean a risk of dangerous bleeding, and the provider may change the dose based on the results. It can also say, with NHLBI, that alcohol can be dangerous with blood thinners and that for one older blood thinner the amount of vitamin K a person eats each day matters, so patients should talk with their provider about their eating patterns and supplements. Leave out target ranges, dose tables, medicine names and food lists that tell a reader what to change. The page explains why the clinic asks these questions; the prescriber answers them for each patient.

Results claims need the same care. A clinic that wants to publish the share of its patients in range, its bleeding rates or its hospital visits needs the data, the measure, the time period, how patients were counted and counsel’s review before the figure goes on a page, and the page states the measure and the period next to it. Without those, describe the service in words: the visit schedule set for each patient, who reviews each result, and how fast the clinic calls back.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. “The safe way to take a blood thinner” implies other care is unsafe even without saying so.

Phrases that need rewriting:

• “Stay in range, every time.” No clinic can promise a blood test result. Describe how the clinic follows up when a result is out of range.
• “Blood thinners without the bleeding risk.” MedlinePlus and NHLBI list bleeding as a side effect, and NHLBI says it can be life-threatening. Remove it.
• “Eat whatever you want on our program.” NHLBI says diet and alcohol matter with blood thinners. Say the clinic reviews diet with each patient.
• “Fewer strokes with our clinic.” An outcome claim. Remove it unless the clinic has the evidence, the measure, the period and counsel’s review.
• “Take this supplement to protect your INR.” MedlinePlus says supplements can affect results. Do not recommend products on the page.

Prices, free INR checks and outside meters

A clinic that posts a self-pay price for visits or home testing follows the rules in our guide to advertising cash prices, and gives uninsured and self-pay patients the estimate described in our guide to good faith estimates.

An anticoagulation clinic adds a few points of its own:

• Say what each price includes and what it does not: the visit, the fingerstick test, a lab draw, home meter training, test strips, result review and calls between visits.
• Say whether the meter and strips come from the clinic or from a separate supplier, and who bills for them.
• A monthly or program price says the length of the commitment, what happens if the patient stops, and how to cancel.
• “Free” INR checks follow 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere.
• A free check at a health fair is still a lab test with a result someone must act on. Say who reviews it and how the person is told.

Referrals, drug makers and meter suppliers

An anticoagulation clinic draws patients from cardiologists, primary care, hospital discharge teams and urgent care, and it deals with drug makers, labs and home meter suppliers. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Where a clinic or its partners bill Medicare or Medicaid, the statute reaches each of these relationships. Rules on referral fees are also set state by state. Our guide to patient and physician referrals covers the general rules.

For an anticoagulation clinic, keep these points:

• Do not give gifts, meals, free services or payments to referring offices or discharge planners in return for patients without counsel’s review.
• Do not take payments, staff or free supplies from a meter supplier or lab in return for steering patients to it. Arrangements with suppliers go to counsel first.
• Funding, meals or speaker fees from blood thinner makers go to counsel first. Payments to physicians may be reported publicly; our guide to Open Payments covers that.
• Patients are not paid or given gifts for choosing the clinic, for switching medicines or for referring friends.
• Clinics that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Reminders, privacy, pixels and ads

An anticoagulation clinic sends a steady run of reminders: test dates, missed results, dose callbacks, and checks before surgery or dental work. Under 45 CFR 164.501, a communication about the clinic’s own treatment for an individual, such as an INR test reminder, a result callback or a refill reminder for a medicine the patient already takes, can fall outside the definition of marketing. A message that promotes a third party’s product, such as a meter, a supplement or a switch to a medicine paid for by its maker, generally needs a signed authorization under 45 CFR 164.508, and a message paid for by a drug or device maker goes to counsel before it is sent. Keep the INR value, the dose and the diagnosis out of text and email message text; our guide to text message appointment reminders covers that wording.

A visit to a blood thinner page, a home testing sign-up or a result upload says something about a person’s health. Keep bookings, intake answers, results and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place and by search terms, and should not be built from a list of patients on blood thinners.

Patient stories

A patient who describes stopping the weekly drive to the lab, or learning to test at home after a clot, can help a reader facing the same routine. It is still one person’s experience. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. “In range every month since I joined” is a results claim. Keep stories to the experience of care, and pair them with the agency wording that the provider sets the dose and the testing schedule.

Get a signed authorization under 45 CFR 164.508 where the clinic is a covered entity, and consent for any photo or video. Name no medicine or meter, say if the patient received anything for taking part, and let the patient review the final version. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two anticoagulation clinic pages

Illustration: a page reads “Blood thinners without the bleeding risk. Our pharmacists manage everything, no doctor needed. Test at home and adjust your own dose. Stay in range, every time. Questions about bleeding? Book an INR check.” It denies a risk the agency pages list, claims powers that depend on an agreement and state law, invites a dose change the FDA page says needs the doctor’s permission, promises a test result and puts a booking link where the warning signs belong.

Illustration: a second page for the same clinic reads “If you take a blood thinner, call us for any sign of serious bleeding, such as red or black stools, bleeding that does not stop, or a fall or bump on the head. If you have chest pain, trouble breathing or cough up blood, call 911. At [Practice name], [Clinician name, license] runs the clinic under a written agreement with [Clinician name, license]. Your prescriber decides your dose and whether home testing suits you. If it does, we train you and check your meter against an office test. Visits at [days and hours]. Call [phone].” It puts the warning signs first, names who is responsible, describes home testing in the FDA words and promises nothing it cannot show.

Checklist before an anticoagulation clinic campaign goes live

• MedlinePlus, NHLBI, FDA and CDC pages named and dated, with a “last reviewed” date and reviewer on each clinical page.
• Bleeding warning signs, the emergency room line and the 911 line above any booking button, and in voicemail, portal replies, text replies, chat and AI front desk tools.
• No tool or message suggests a dose change; the prescriber sets the dose.
• Pharmacist services described as the written agreement and the state’s law allow, with the responsible prescriber named, checked for each state served.
• Home testing described in the FDA words: prescribed, trained, meter checked against an office test, results reviewed by the clinic; no meter or maker names.
• No target ranges, dose tables, medicine names or diet instructions on marketing pages; no “stay in range” or “no bleeding risk” lines.
• Outcome numbers only with data, measure, period and counsel’s review.
• Prices say what is included, who supplies and bills for the meter, and how to cancel; free offers follow 16 CFR 251.1.
• No gifts or payments to referral sources; supplier, lab and drug maker arrangements reviewed by counsel.
• Reminders about the clinic’s own care only; no INR value, dose or diagnosis in message text; third-party promotions only with a signed authorization.
• Bookings and results stay out of pixels and ad audiences; targeting by place and search terms only.
• Stories have signed authorizations, name no medicine or meter, make no results claim and carry a statement of what people can generally expect.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including pharmacies and practices that run anticoagulation services. For an anticoagulation clinic, that means a site that quotes MedlinePlus, NHLBI and FDA as written, puts the bleeding warning signs above the booking button, explains the pharmacist’s role and home testing in plain words, and names who is responsible, plus booking and contact forms that keep results and medicines off the web and away from tracking tools. Our front desk tools hand urgent messages to the emergency wording and the 911 line, and do not triage symptoms or discuss doses. We do not decide who takes a blood thinner or at what dose; your prescribers do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• MedlinePlus: Blood Thinners (last updated June 27, 2024)
• MedlinePlus: Prothrombin Time Test and INR (PT/INR) (last updated May 15, 2024)
• MedlinePlus Medical Encyclopedia: Pulmonary embolus (review date October 21, 2025)
• MedlinePlus Medical Encyclopedia: Deep venous thrombosis (review date April 1, 2025)
• NHLBI: Venous Thromboembolism, Treatment (last updated on September 20, 2022)
• NHLBI: Venous Thromboembolism, Recovery (last updated on September 20, 2022)
• FDA: Prothrombin Time, home use test (content current as of September 27, 2018)
• CDC: Advancing Team-Based Care Through Collaborative Practice Agreements (2017)
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing